New hope for early detection of stomach cancer

March 17, 2014 by Robyn Mills, University of Adelaide

(Medical Xpress)—University of Adelaide research has provided new hope for the early detection of stomach cancer with the identification of four new biomarkers in the blood of human cancer patients.

Stomach or gastric cancer is the fourth most common cancer in the world and the second leading cause of death due to cancer.

"Stomach cancer is typically without symptoms in the early stages so most cancers are not diagnosed until the later stages, and the survival rates are therefore low," says Associate Professor Peter Hoffmann, project leader and Director of the University's Adelaide Proteomics Centre.

"Endoscopic investigations are invasive and expensive and most are generally not conducted until the cancer is at an advanced stage.

"A non-invasive, inexpensive screening technique through a simple blood test for the of stomach cancer would make a huge difference in the survival outcomes for people with this disease."

Published in the journal Biochimica et Biophysica Acta, the researchers have identified four new proteins that change in concentration in the blood of stomach cancer patients.

In this latest research, conducted by Dr Julia Humphries who is now at SA Pathology and Dr Megan Penno, they showed differences in the four protein levels between serum samples from 37 patients, including 11 early stage , and the controls which included healthy and non-cancerous patients with other gastric disease.

All four proteins - afamin, clusterin, haptoglobin and vitamin D binding protein (VDBP) - were individually superior to a current clinical marker CA72-4 in discriminating stomach cancer from healthy controls.

"Using the four markers together produces high levels of selectivity and sensitivity in detecting ," says Associate Professor Hoffmann.

Explore further: New AGA/GCF research grant to fund exploration of the development of gastric cancer

More information: Julia M. Humphries, Megan A.S. Penno, Florian Weiland, Manuela Klingler-Hoffmann, Agnieszka Zuber, Alex Boussioutas, Matthias Ernst, Peter Hoffmann, "Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer," Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Available online 7 February 2014, ISSN 1570-9639, dx.doi.org/10.1016/j.bbapap.2014.01.018.

Related Stories

New AGA/GCF research grant to fund exploration of the development of gastric cancer

March 11, 2014
The American Gastroenterological Association (AGA) Research Foundation and the Gastric Cancer Foundation (GCF) are pleased to announce that the first AGA–Gastric Cancer Foundation Research Scholar Award in Gastric and Esophageal ...

Scientists develop a breath test that could detect stomach cancers

March 6, 2013
A new type of breath test that detects nanoparticles could help diagnose stomach cancers, according to a study published in the British Journal of Cancer.

Study reveals optimal interval for stomach cancer screening

July 16, 2012
A new study has determined how often people should get screened for gastric or stomach cancer in high-risk regions of the world. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the ...

Existing medicines show promise for treating stomach and bowel cancer

February 4, 2014
(Medical Xpress)—Stomach and bowel cancer, two of the most common cancers worldwide, could be treated with a class of medicines that are currently used to treat a blood disorder, a Melbourne research team has discovered.

Stomach bacteria switch off human immune defences to cause disease

September 1, 2013
Helicobacter pylori is a bacterium that establishes a life-long stomach infection in humans, which in some cases can lead to duodenal ulcers or stomach cancer. New research, presented at this week's Society for General Microbiology ...

Scientists discover how stomach cancer spreads

November 13, 2012
Scientists at the University of Liverpool have found that the production of a protein that prevents the growth and spread of cancerous cells is impaired in patients with gastric cancer.

Recommended for you

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Scientists block the siren call of two aggressive cancers

January 23, 2018
Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.